AWA
OVID icon

Aaron Wealth Advisors’s Ovid Therapeutics OVID Stock Holding History

Aaron Wealth Advisors’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2K Hold
11,234
– – ﹤0.01% 686
2026
Q1 		$24.9K Hold
11,234
– – ﹤0.01% 689
2025
Q4 		$18.3K Hold
11,234
– – ﹤0.01% 675
2025
Q3 		$14.6K Sell
11,234
-27,025
-71% -$23.4K ﹤0.01% 629
2025
Q2 		$12.6K Buy
+38,259
New +$11.5K ﹤0.01% 486

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Aaron Wealth Advisors's OVID Position: Q2 2026 in Review

Aaron Wealth Advisors held its Ovid Therapeutics (OVID) position steady in Q2 2026 at 11,234 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

Aaron Wealth Advisors first reported a position in OVID in Q2 2025 and has held it in 5 quarters since. 131 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Aaron Wealth Advisors held 11,234 shares of Ovid Therapeutics worth $30.2K as of Q2 2026.
  • Aaron Wealth Advisors left its Ovid Therapeutics share count unchanged in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of Aaron Wealth Advisors's portfolio in Q2 2026, its #686 holding.
  • Aaron Wealth Advisors first reported a position in Ovid Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 131 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.